![Daniel Ripley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Ripley
Plus aucun poste en cours
Profil
Daniel L.
Ripley worked as an Associate Director of Business Development at Orchestra Therapeutics, Inc. He then served as the Director of Business Development at Ionis Pharmaceuticals, Inc. from 2000 to 2006.
In 2011, he worked as the Senior Director of Business Development at Apricus Biosciences, Inc. From 2006 to 2008, he held the position of Senior Director of Business Development at Kalypsys, Inc. Prior to that, he was the Director of Business Development at Orchestra Therapeutics, Inc. from 1997 to 2000.
From 2012 to 2019, he worked as the Senior Vice President of Business Development and Programme at Conatus Pharmaceuticals, Inc. In 2009 and 2010, he served as the Vice President of Business Development at BioBlocks, Inc. He also held the position of Senior Vice President of Business Development at Hightide Therapeutics, Inc. Mr. Ripley completed his undergraduate degree and MBA at San Diego State University.
Anciens postes connus de Daniel Ripley
| Sociétés | Poste | Fin |
|---|---|---|
| HISTOGEN INC. | Directeur/Membre du Conseil | 02/10/2012 |
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Corporate Officer/Principal | 01/01/2012 |
BioBlocks, Inc.
 BioBlocks, Inc. BiotechnologyHealth Technology Provides medicinal chemistry drug discovery services and products to clients | Corporate Officer/Principal | 01/01/2010 |
Kalypsys, Inc.
 Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases | Corporate Officer/Principal | 01/01/2008 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2006 |
Formation de Daniel Ripley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Orchestra Therapeutics, Inc.
 Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Health Technology |
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases | Health Technology |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of human therapeutics to treat liver diseases | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioBlocks, Inc.
BioBlocks, Inc. BiotechnologyHealth Technology Provides medicinal chemistry drug discovery services and products to clients | Health Technology |
Hightide Therapeutics, Inc.
 Hightide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of therapies for the treatment of metabolic and digestive diseases | Health Technology |
